» Articles » PMID: 25870064

Factors Associated with Antibiotic Misuse in Outpatient Treatment for Upper Respiratory Tract Infections

Overview
Specialty Pharmacology
Date 2015 Apr 15
PMID 25870064
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The Centers for Disease Control and Prevention has promoted the appropriate use of antibiotics since 1995 when it initiated the National Campaign for Appropriate Antibiotic Use in the Community. This study examined upper respiratory tract infections included in the campaign to determine the degree to which antibiotics were appropriately prescribed and subsequent admission rates in a veteran population. This study was a retrospective chart review conducted among outpatients with a diagnosis of a respiratory tract infection, including bronchitis, pharyngitis, sinusitis, or nonspecific upper respiratory tract infection, between January 2009 and December 2011. The study found that 595 (35.8%) patients were treated appropriately, and 1,067 (64.2%) patients received therapy considered inappropriate based on the Get Smart Campaign criteria. Overall the subsequent readmission rate was 1.5%. The majority (77.5%) of patients were prescribed an antibiotic. The most common antibiotics prescribed were azithromycin (39.0%), amoxicillin-clavulanate (13.2%), and moxifloxacin (7.5%). A multivariate regression analysis demonstrated significant predictors of appropriate treatment, including the presence of tonsillar exudates (odds ratio [OR], 0.6; confidence interval [CI], 0.3 to 0.9), fever (OR, 0.6; CI, 0.4 to 0.9), and lymphadenopathy (OR, 0.4; CI, 0.3 to 0.6), while penicillin allergy (OR, 2.9; CI, 1.7 to 4.7) and cough (OR, 1.6; CI, 1.1 to 2.2) were significant predictors for inappropriate treatment. Poor compliance with the Get Smart Campaign was found in outpatients for respiratory infections. Results from this study demonstrate the overprescribing of antibiotics, while providing a focused view of improper prescribing. This article provides evidence that current efforts are insufficient for curtailing inappropriate antibiotic use.

Citing Articles

Behaviour change interventions addressing antibiotic treatment seeking behaviour for respiratory tract infections in primary care settings: A scoping review protocol.

Maher A, Roche K, C Morrissey E, Murphy A, Sheaf G, Ryan C HRB Open Res. 2025; 7:41.

PMID: 40027903 PMC: 11869197. DOI: 10.12688/hrbopenres.13831.1.


Understanding patient demand for and use of antibiotics for upper respiratory tract infection: A qualitative application of the Necessity-Concerns Framework in Saudi Arabia.

Almeshal N, Foot H, Clarke A, Chan A, Horne R Front Pharmacol. 2024; 15:1399698.

PMID: 38962318 PMC: 11220495. DOI: 10.3389/fphar.2024.1399698.


Determinants of appropriate antibiotic and NSAID prescribing in unscheduled outpatient settings in the veterans health administration.

Ward M, Matheny M, Rubenstein M, Bonnet K, DAgostino C, Schlundt D BMC Health Serv Res. 2024; 24(1):640.

PMID: 38760660 PMC: 11102113. DOI: 10.1186/s12913-024-11082-0.


Lemierre syndrome: a hidden complication of sore throats.

AlAmer N, ALMarzouq W Int J Emerg Med. 2023; 16(1):45.

PMID: 37488492 PMC: 10364365. DOI: 10.1186/s12245-023-00524-x.


Weighing patient attributes in antibiotic prescribing for upper respiratory tract infections: A discrete choice experiment on primary care physicians in Hubei Province, China.

Xue T, Liu C, Li Z, Liu J, Tang Y Front Public Health. 2023; 10:1008217.

PMID: 36605239 PMC: 9807867. DOI: 10.3389/fpubh.2022.1008217.


References
1.
Aspinall S, Metlay J, Maselli J, Gonzales R . Impact of hospital formularies on fluoroquinolone prescribing in emergency departments. Am J Manag Care. 2007; 13(5):241-8. View

2.
Hicks L, Taylor Jr T, Hunkler R . U.S. outpatient antibiotic prescribing, 2010. N Engl J Med. 2013; 368(15):1461-2. DOI: 10.1056/NEJMc1212055. View

3.
Gonzales R, Malone D, Maselli J, Sande M . Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001; 33(6):757-62. DOI: 10.1086/322627. View

4.
E Pichichero M . Dynamics of antibiotic prescribing for children. JAMA. 2002; 287(23):3133-5. DOI: 10.1001/jama.287.23.3133. View

5.
Neuhauser M, Weinstein R, Rydman R, Danziger L, Karam G, Quinn J . Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA. 2003; 289(7):885-8. DOI: 10.1001/jama.289.7.885. View